
Becton, Dickinson and Company (BDX:NYSE) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends
Description
Becton, Dickinson and Company (BDX:NYSE) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends
Report Summary
Becton, Dickinson and Company (BDX:NYSE) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Trends Report is a comprehensive and easily accessible overview of Becton, Dickinson and Company's business operations. It provides a detailed analysis of the company's financial and strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.
The report begins with in-depth information about Becton, Dickinson and Company including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.
Next, the report assesses Becton, Dickinson and Company's strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. The PESTLE analysis evaluates the external factors impacting the company's operations and market environment. Additionally, By integrating these strategic analyses, the report offers a comprehensive understanding of Becton, Dickinson and Company's overall strategic standing and supports informed decision-making and strategic planning.
The report also covers Becton, Dickinson and Company's financial analysis basis of latest income statement, balance sheet, and cash flow statement. Key financial ratios related to profitability, asset turnover, credit, market, and long-term solvency are outlined, providing guidance for investment decisions. Furthermore, the report compares Becton, Dickinson and Company's financial parameters with those of its competitors, offering a unique analysis of the competitive landscape. This information helps manage the business environment and improve sales activities by gaining insight into competitors' operations.
Finally, the report includes recent news and deal activities undertaken by Becton, Dickinson and Company enhancing awareness of the company's business trends, growth perspectives, and more.
Key Highlights
BD is a global medical technology company engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. It provide customer solutions that are focused on improving medication management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; improving drug delivery; aiding anesthesiology care; enhancing the diagnosis of infectious diseases and cancers; and advancing cellular research and applications. BD’s operations consist of three worldwide business segments: BD Medical, BD Life Sciences and BD Interventional. The company was incorporated under the laws of the State of New Jersey in November 1906 with headquartered in United States.
Becton, Dickinson and Company in the News:-
- 10-Jul-2024 - BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials
- 10-Jul-2024 - BD Surpasses Scope 1 and 2 Reduction Milestones for FY 2023
- 03-Jul-2024 - BD to Announce Financial Results for its Third Quarter of Fiscal 2024
- 26-Jun-2024 - New BD Research Tool Helps Scientists Study Cells that are Often Key Culprits in the Development of Cancer and Infectious Diseases
- 20-Jun-2024 - BD Announces Dates for Third Quarter and Fourth Quarter Fiscal 2024 Earnings Webcasts
Scope
- Tactical Analysis:- Various strategic frameworks to gain insights into a company's competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
- Business Strategy:- Contributes to shaping the company's overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
- Financial Position:- Provide valuable information on the financial performance and investor sentiment surrounding the company. Indicating the level of confidence and expectations in the company's future prospects. These components collectively contribute to understanding the financial health and market perception of the company.
- Company Fundamentals:- These fundamentals offer valuable insights into the company's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
- Competitive Landscape:- An identification of the company's main competitors, providing insights into the competitive landscape it operates in.
- Comprehensive Understanding of the Becton, Dickinson and Company's internal and external factors through SWOT analysis, PESTLE analysis, Financial Analysis, and Competitors Benchmarking.
- Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
- Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
- Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
- Financial Performance Evaluation provides crucial insights into key financial ratios and trends, supporting better financial decision-making and resource allocation.
- Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.
- Becton, Dickinson and Company Value Chain Analysis
- Becton, Dickinson and Company Porter's Five Forces Analysis
- Becton, Dickinson and Company VRIO Analysis
- Becton, Dickinson and Company BCG Analysis
- Becton, Dickinson and Company Segmentation, Targeting and Positioning (STP) Analysis
- Becton, Dickinson and Company Ansoff Matrix Analysis
Table of Contents
124 Pages
- COMPANY EXECUTIVE SUMMARY
- Table of Contents
- Tables
- Charts
- Becton, Dickinson and Company - Key Company Facts
- Becton, Dickinson and Company - Company Description
- Becton, Dickinson and Company - Top Executives
- Becton, Dickinson and Company- Top Executives Biographies
- Becton, Dickinson and Company- Head Office & Locations
- Head Office - Country
- Key Subsidiaries
- Becton, Dickinson and Company - Products and Services
- Products
- Becton, Dickinson and Company - Historic Events
- Becton, Dickinson and Company - Company's Management Discussion
- Becton, Dickinson and Company - Corporate Strategy
- Becton, Dickinson and Company - Business Description
- BD Medical
- BD Life Sciences
- BD Interventional
- Becton, Dickinson and Company - ESG Spotlight
- Environment
- Social
- Corporate Governance
- Becton, Dickinson and Company - SWOT Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Becton, Dickinson and Company - PESTLE Analysis
- Overview
- Political Factors
- Economic Factors
- Social Factors
- Technological Factors
- Legal Factors
- Environmental Factors
- Becton, Dickinson and Company - Financial Deep Dive
- Share Price Trend - Aug-2023 to Aug-2024 (Average Share Closing Price)
- Profit and Loss Statement
- Summary of Profit and Loss Statement
- Balance Sheet
- Summary of Balance Sheet
- Cash Flow Statement
- Summary of Cash Flow Statement
- Key Financial Ratio Analysis
- Becton, Dickinson and Company - Ratio Charts
- Activity Ratio Charts
- Growth Ratios Charts
- Leverage Ratio Charts
- Liquidity Ratio Charts
- Profitability Ratio Charts
- Competing Players
- Snapshot of Competing Players
- Baxter International Inc.
- Key Company Facts
- Company Description
- Snapshot of Competing Players
- Koninklijke Philips N.V.
- Key Company Facts
- Company Description
- Snapshot of Competing Players
- Medtronic plc
- Key Company Facts
- Company Description
- Snapshot of Competing Players
- Stryker Corporation
- Key Company Facts
- Company Description
- Snapshot of Competing Players
- Thermo Fisher Scientific Inc.
- Key Company Facts
- Company Description
- Becton, Dickinson and Company - In the News
- 10-Jul-2024 - BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials
- 10-Jul-2024 - BD Surpasses Scope 1 and 2 Reduction Milestones for FY 2023
- 03-Jul-2024 - BD to Announce Financial Results for its Third Quarter of Fiscal 2024
- 26-Jun-2024 - New BD Research Tool Helps Scientists Study Cells that are Often Key Culprits in the Development of Cancer and Infectious Diseases
- 20-Jun-2024 - BD Announces Dates for Third Quarter and Fourth Quarter Fiscal 2024 Earnings Webcasts
- 06-May-2024 - BD, City of Hope to Offer Pharmacy Residency Program for Medication-Use Safety and Policy
- 30-Apr-2024 - BD Board Declares Dividend
- 29-Apr-2024 - BD to Present at Bank of America Securities Health Care Conference 2024
- 09-Apr-2024 - BD Named a Best Employer for Excellence in Employee Well-Being
- 27-Mar-2024 - New Survey Reveals Patients Receive Too Many Needlesticks
- 26-Mar-2024 - BD Named Among Fortune's Most Innovative Companies
- 21-Mar-2024 - BD Increases Domestic Production to Support U.S. Health Care Need for Syringes
- 18-Mar-2024 - BD and Health Care Consortium in Denmark Find Success in Medical Waste Recycling Study
- 13-Mar-2024 - New Study Highlights Benefits of Medication Management Automation in Long-Term Care Facilities
- 11-Mar-2024 - BD Names Rian Seger President of BD Surgery
- Becton, Dickinson and Company - Key Deals
- 14-Mar-2024 - BD Collaborates with GOCC to Combat Sepsis in Poland
- 21-Feb-2024 - BD Partners with Camtech Health to Increase Access to Cervical Cancer Screening in Singapore
- 30-Jan-2024 - BD, Techcyte Announce Strategic Collaboration to Offer AI-Based Digital Cervical Cytology System for Pap Testing
- 23-Jan-2024 - BD, Hamilton Collaborate to Standardize Single-Cell Multiomics Experiments Using Robotics
- 20-Nov-2023 - BD, Bio Farma Collaborate to Help Eliminate Tuberculosis in Indonesia by 2030
- 03-Aug-2023 - Bill & Melinda Gates Foundation, Children's Investment Fund Foundation, Pfizer and Becton, Dickinson & Company Expand Partnership for Greater Access to Injectable Contraceptive for Women in Low- and Lower-Middle-Income Countries
- Appendix
- Definitions
- SWOT Analysis
- PESTLE Analysis
- Value Chain Analysis
- ESG Spotlight
- Financial Deep Dive
- Financial Ratios -
- Activity Ratios
- Growth Ratios
- Leverage Ratios
- Liquidity Ratios
- Market Ratios
- Profitability Ratios
- Research Methodology
- Disclaimer
- Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.